Eric Karran

Biog:
Approx. Dr Eric Karran has spent most of his career in the pharmaceutical industry holding CSO and VP roles at SmithKline Beecham (now GSK), Pfizer, Eli Lilly and Johnson and Johnson. Eric has specialized in Neuroscience research, and particularly Alzheimer’s disease, for the past 20 years, participating in a number of late-stage clinical programmes. Eric is a Visiting Professor at the Catholic University of Leuven, Belgium, and an Honorary Senior Research Associate at the Institute of Neurology, University College London. He is currently the Director of Research for Alzheimer’s Research UK .